Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Diabetes Mellitus, Type 1 | 18 | 2022 | 3323 | 2.110 |
Why?
|
Insulin Infusion Systems | 7 | 2022 | 212 | 1.690 |
Why?
|
Probiotics | 3 | 2020 | 350 | 1.350 |
Why?
|
Decision Support Systems, Clinical | 5 | 2022 | 1162 | 1.090 |
Why?
|
Child Nutritional Physiological Phenomena | 2 | 2018 | 303 | 1.040 |
Why?
|
User-Computer Interface | 4 | 2021 | 1423 | 1.030 |
Why?
|
Meningitis, Meningococcal | 2 | 2015 | 44 | 1.010 |
Why?
|
Malpractice | 4 | 2015 | 568 | 1.000 |
Why?
|
Meningococcal Vaccines | 2 | 2015 | 98 | 0.970 |
Why?
|
Electronic Health Records | 11 | 2022 | 4426 | 0.900 |
Why?
|
Blood Glucose Self-Monitoring | 5 | 2022 | 430 | 0.870 |
Why?
|
Infant Nutritional Physiological Phenomena | 2 | 2016 | 344 | 0.860 |
Why?
|
Cerebral Palsy | 2 | 2018 | 457 | 0.840 |
Why?
|
Insulin | 9 | 2022 | 6569 | 0.840 |
Why?
|
Large-Conductance Calcium-Activated Potassium Channel alpha Subunits | 1 | 2021 | 19 | 0.810 |
Why?
|
Microbiology | 2 | 2019 | 73 | 0.800 |
Why?
|
Flour | 1 | 2020 | 18 | 0.770 |
Why?
|
Micronutrients | 4 | 2019 | 364 | 0.740 |
Why?
|
Hypoglycemic Agents | 9 | 2022 | 2861 | 0.640 |
Why?
|
Iron Metabolism Disorders | 1 | 2017 | 27 | 0.620 |
Why?
|
Data Display | 1 | 2018 | 184 | 0.620 |
Why?
|
Parasites | 1 | 2020 | 162 | 0.610 |
Why?
|
Clinical Laboratory Information Systems | 1 | 2018 | 107 | 0.610 |
Why?
|
Thiazolidines | 2 | 2015 | 74 | 0.600 |
Why?
|
Fungi | 1 | 2020 | 327 | 0.600 |
Why?
|
Pyrrolidonecarboxylic Acid | 2 | 2015 | 65 | 0.600 |
Why?
|
Leydig Cell Tumor | 1 | 2016 | 25 | 0.590 |
Why?
|
Basal Metabolism | 1 | 2018 | 169 | 0.590 |
Why?
|
Congenital Abnormalities | 1 | 2021 | 708 | 0.560 |
Why?
|
Neisseria meningitidis, Serogroup B | 1 | 2015 | 7 | 0.550 |
Why?
|
Energy Intake | 3 | 2019 | 2135 | 0.550 |
Why?
|
Nutrition Assessment | 2 | 2017 | 717 | 0.550 |
Why?
|
Infant, Newborn, Diseases | 1 | 2021 | 578 | 0.540 |
Why?
|
Italy | 6 | 2020 | 827 | 0.530 |
Why?
|
Thioctic Acid | 1 | 2015 | 23 | 0.530 |
Why?
|
Functional Food | 1 | 2015 | 19 | 0.530 |
Why?
|
Hospital Information Systems | 1 | 2018 | 395 | 0.530 |
Why?
|
Disabled Children | 1 | 2018 | 247 | 0.530 |
Why?
|
Adolescent Nutritional Physiological Phenomena | 1 | 2015 | 63 | 0.530 |
Why?
|
Fibroblast Growth Factors | 1 | 2021 | 879 | 0.520 |
Why?
|
Prenatal Nutritional Physiological Phenomena | 1 | 2016 | 159 | 0.510 |
Why?
|
Vicia faba | 1 | 2014 | 3 | 0.510 |
Why?
|
Favism | 1 | 2014 | 3 | 0.510 |
Why?
|
Nutritional Status | 4 | 2018 | 1587 | 0.500 |
Why?
|
Child | 31 | 2022 | 77033 | 0.490 |
Why?
|
Malnutrition | 2 | 2018 | 613 | 0.490 |
Why?
|
Compensation and Redress | 1 | 2014 | 71 | 0.480 |
Why?
|
Glucosephosphate Dehydrogenase Deficiency | 1 | 2014 | 89 | 0.480 |
Why?
|
Respiratory Tract Infections | 3 | 2022 | 956 | 0.470 |
Why?
|
Insurance, Liability | 1 | 2014 | 102 | 0.470 |
Why?
|
Infant | 18 | 2022 | 34923 | 0.470 |
Why?
|
Dermatitis, Atopic | 1 | 2020 | 644 | 0.470 |
Why?
|
Herpes Zoster Ophthalmicus | 1 | 2013 | 37 | 0.470 |
Why?
|
Retinal Vasculitis | 1 | 2013 | 42 | 0.460 |
Why?
|
Pneumococcal Vaccines | 2 | 2015 | 391 | 0.460 |
Why?
|
Child, Preschool | 18 | 2022 | 40802 | 0.460 |
Why?
|
Uveitis, Anterior | 1 | 2013 | 101 | 0.450 |
Why?
|
Vaccines, Conjugate | 1 | 2015 | 332 | 0.450 |
Why?
|
Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2014 | 285 | 0.440 |
Why?
|
Paroxetine | 1 | 2013 | 182 | 0.440 |
Why?
|
Intestines | 2 | 2020 | 1919 | 0.430 |
Why?
|
Posterior Leukoencephalopathy Syndrome | 1 | 2013 | 51 | 0.430 |
Why?
|
Herpesvirus 3, Human | 1 | 2013 | 207 | 0.430 |
Why?
|
Feeding Behavior | 2 | 2016 | 3180 | 0.430 |
Why?
|
Folliculitis | 1 | 2012 | 28 | 0.420 |
Why?
|
Medical Records Systems, Computerized | 2 | 2018 | 1205 | 0.420 |
Why?
|
Diagnostic Tests, Routine | 1 | 2018 | 789 | 0.420 |
Why?
|
Pulmonary Diffusing Capacity | 1 | 2011 | 88 | 0.410 |
Why?
|
Adjuvants, Immunologic | 2 | 2015 | 995 | 0.410 |
Why?
|
Rotavirus Vaccines | 1 | 2012 | 64 | 0.410 |
Why?
|
Rotavirus Infections | 1 | 2012 | 86 | 0.400 |
Why?
|
Skin Diseases, Vesiculobullous | 1 | 2012 | 85 | 0.400 |
Why?
|
Biological Products | 1 | 2020 | 850 | 0.400 |
Why?
|
Plagiocephaly, Nonsynostotic | 1 | 2011 | 29 | 0.390 |
Why?
|
Diet, Gluten-Free | 1 | 2013 | 271 | 0.390 |
Why?
|
Carbamates | 1 | 2012 | 196 | 0.380 |
Why?
|
Excipients | 1 | 2011 | 94 | 0.380 |
Why?
|
Nutritive Value | 1 | 2013 | 335 | 0.380 |
Why?
|
Drug Eruptions | 1 | 2013 | 295 | 0.380 |
Why?
|
Ritonavir | 1 | 2012 | 324 | 0.370 |
Why?
|
Testicular Neoplasms | 1 | 2016 | 758 | 0.370 |
Why?
|
Diarrhea | 1 | 2017 | 1342 | 0.370 |
Why?
|
Pneumococcal Infections | 1 | 2015 | 497 | 0.360 |
Why?
|
Pediatrics | 3 | 2015 | 3454 | 0.360 |
Why?
|
Diabetic Angiopathies | 1 | 2015 | 821 | 0.360 |
Why?
|
HIV Protease Inhibitors | 1 | 2012 | 435 | 0.360 |
Why?
|
Insurance Claim Review | 1 | 2014 | 720 | 0.350 |
Why?
|
Humans | 83 | 2022 | 739398 | 0.350 |
Why?
|
Klippel-Trenaunay-Weber Syndrome | 1 | 2009 | 68 | 0.340 |
Why?
|
Exanthema | 1 | 2013 | 491 | 0.340 |
Why?
|
Carbon Monoxide | 1 | 2011 | 526 | 0.330 |
Why?
|
Medical Errors | 2 | 2014 | 1291 | 0.320 |
Why?
|
Colitis, Ulcerative | 1 | 2020 | 1899 | 0.320 |
Why?
|
Health Knowledge, Attitudes, Practice | 2 | 2014 | 3908 | 0.310 |
Why?
|
Product Surveillance, Postmarketing | 1 | 2012 | 439 | 0.310 |
Why?
|
Status Epilepticus | 1 | 2013 | 435 | 0.310 |
Why?
|
Eosinophilia | 1 | 2012 | 531 | 0.310 |
Why?
|
Adolescent | 21 | 2022 | 85405 | 0.310 |
Why?
|
Adverse Drug Reaction Reporting Systems | 1 | 2011 | 474 | 0.310 |
Why?
|
Crohn Disease | 1 | 2020 | 2299 | 0.300 |
Why?
|
Immunosuppressive Agents | 1 | 2020 | 4143 | 0.300 |
Why?
|
Cerebrovascular Disorders | 1 | 2014 | 1497 | 0.300 |
Why?
|
Interdisciplinary Communication | 1 | 2013 | 952 | 0.300 |
Why?
|
Antioxidants | 1 | 2015 | 1659 | 0.300 |
Why?
|
Hyperglycemia | 2 | 2017 | 1357 | 0.290 |
Why?
|
Oligopeptides | 1 | 2012 | 1179 | 0.290 |
Why?
|
Drugs, Generic | 1 | 2012 | 423 | 0.290 |
Why?
|
Workflow | 3 | 2022 | 831 | 0.290 |
Why?
|
Dietary Supplements | 2 | 2017 | 3279 | 0.280 |
Why?
|
Blood Glucose | 7 | 2022 | 6237 | 0.280 |
Why?
|
Overweight | 1 | 2017 | 2355 | 0.270 |
Why?
|
Diabetes Mellitus | 2 | 2021 | 5702 | 0.270 |
Why?
|
Celiac Disease | 1 | 2013 | 783 | 0.270 |
Why?
|
Infant, Newborn | 10 | 2022 | 25470 | 0.270 |
Why?
|
Diet Records | 2 | 2019 | 420 | 0.270 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2020 | 2397 | 0.260 |
Why?
|
Male | 36 | 2022 | 349022 | 0.260 |
Why?
|
Influenza, Human | 2 | 2009 | 1476 | 0.260 |
Why?
|
Mutation, Missense | 1 | 2014 | 2552 | 0.250 |
Why?
|
Ambulatory Care | 2 | 2017 | 2711 | 0.250 |
Why?
|
Diabetes Complications | 1 | 2011 | 1356 | 0.240 |
Why?
|
Attitude of Health Personnel | 2 | 2019 | 3844 | 0.240 |
Why?
|
Immunocompromised Host | 2 | 2013 | 845 | 0.230 |
Why?
|
Antiretroviral Therapy, Highly Active | 1 | 2012 | 1896 | 0.230 |
Why?
|
Immunization Schedule | 2 | 2015 | 219 | 0.230 |
Why?
|
Nutritional Requirements | 2 | 2015 | 283 | 0.230 |
Why?
|
Female | 30 | 2022 | 378853 | 0.230 |
Why?
|
Dietary Fiber | 2 | 2019 | 759 | 0.220 |
Why?
|
Exercise | 2 | 2018 | 5591 | 0.220 |
Why?
|
Sulfonamides | 1 | 2012 | 1934 | 0.220 |
Why?
|
Influenza Vaccines | 1 | 2009 | 740 | 0.200 |
Why?
|
Channelopathies | 1 | 2021 | 32 | 0.200 |
Why?
|
Computer Simulation | 1 | 2015 | 6237 | 0.200 |
Why?
|
Ribonuclease H | 1 | 2021 | 44 | 0.200 |
Why?
|
Models, Biological | 1 | 2018 | 9609 | 0.200 |
Why?
|
Down Syndrome | 1 | 2009 | 873 | 0.200 |
Why?
|
Peritoneal Dialysis | 1 | 2022 | 146 | 0.190 |
Why?
|
Health Promotion | 1 | 2013 | 2187 | 0.190 |
Why?
|
Anti-Retroviral Agents | 1 | 2011 | 1734 | 0.190 |
Why?
|
Carbohydrate Metabolism, Inborn Errors | 1 | 2020 | 31 | 0.190 |
Why?
|
Anti-Bacterial Agents | 2 | 2017 | 7136 | 0.190 |
Why?
|
Pyridines | 1 | 2012 | 2810 | 0.190 |
Why?
|
Aging | 1 | 2019 | 8613 | 0.190 |
Why?
|
Skin Diseases, Infectious | 1 | 2020 | 74 | 0.190 |
Why?
|
Practice Guidelines as Topic | 1 | 2017 | 7274 | 0.190 |
Why?
|
Fermentation | 1 | 2020 | 138 | 0.180 |
Why?
|
Autoimmune Diseases of the Nervous System | 1 | 2021 | 67 | 0.180 |
Why?
|
Skin | 1 | 2013 | 4324 | 0.180 |
Why?
|
Patient Acceptance of Health Care | 1 | 2014 | 3021 | 0.180 |
Why?
|
Influenza A virus | 1 | 2003 | 461 | 0.170 |
Why?
|
Nervous System Malformations | 1 | 2021 | 244 | 0.170 |
Why?
|
Antigens, Bacterial | 2 | 2015 | 1170 | 0.170 |
Why?
|
Meconium | 1 | 2018 | 48 | 0.160 |
Why?
|
Double-Blind Method | 4 | 2020 | 11985 | 0.160 |
Why?
|
Sodium-Glucose Transport Proteins | 1 | 2018 | 8 | 0.160 |
Why?
|
RNA, Viral | 2 | 2020 | 2907 | 0.160 |
Why?
|
Vaccination | 3 | 2015 | 3232 | 0.160 |
Why?
|
Nitric Oxide Synthase Type II | 1 | 2020 | 534 | 0.160 |
Why?
|
Receptors, Purinergic P2X7 | 1 | 2018 | 85 | 0.160 |
Why?
|
Weight Loss | 2 | 2021 | 2589 | 0.160 |
Why?
|
Host-Parasite Interactions | 1 | 2020 | 293 | 0.160 |
Why?
|
Phosphates | 1 | 2021 | 785 | 0.150 |
Why?
|
Calorimetry, Indirect | 1 | 2018 | 182 | 0.150 |
Why?
|
Acute Disease | 4 | 2022 | 7128 | 0.150 |
Why?
|
Diet | 1 | 2015 | 7876 | 0.150 |
Why?
|
Endothelium | 1 | 2020 | 776 | 0.150 |
Why?
|
HIV Infections | 3 | 2015 | 16764 | 0.150 |
Why?
|
Hematopoietic Stem Cells | 2 | 2021 | 3364 | 0.150 |
Why?
|
RNA, Ribosomal, 16S | 1 | 2020 | 946 | 0.150 |
Why?
|
Milk Hypersensitivity | 1 | 2018 | 75 | 0.150 |
Why?
|
Cohort Studies | 7 | 2022 | 40389 | 0.140 |
Why?
|
Hypoglycemia | 2 | 2015 | 855 | 0.140 |
Why?
|
Amino Acid Substitution | 1 | 2021 | 1793 | 0.140 |
Why?
|
Anti-HIV Agents | 1 | 2012 | 4320 | 0.140 |
Why?
|
Systems Integration | 1 | 2018 | 441 | 0.140 |
Why?
|
Anthropometry | 2 | 2020 | 1344 | 0.140 |
Why?
|
Area Under Curve | 2 | 2011 | 1655 | 0.140 |
Why?
|
Risk Factors | 7 | 2020 | 71974 | 0.140 |
Why?
|
Age Factors | 3 | 2020 | 18349 | 0.130 |
Why?
|
Treatment Outcome | 8 | 2021 | 62693 | 0.130 |
Why?
|
Young Adult | 9 | 2020 | 56255 | 0.130 |
Why?
|
Puberty, Precocious | 1 | 2016 | 155 | 0.130 |
Why?
|
Risk | 3 | 2020 | 9684 | 0.130 |
Why?
|
Furosemide | 1 | 2015 | 167 | 0.130 |
Why?
|
Cucurbita | 1 | 2014 | 6 | 0.130 |
Why?
|
Remission Induction | 1 | 2020 | 2378 | 0.120 |
Why?
|
Feces | 1 | 2020 | 1389 | 0.120 |
Why?
|
Decision Making, Computer-Assisted | 1 | 2015 | 150 | 0.120 |
Why?
|
Serotyping | 1 | 2015 | 339 | 0.120 |
Why?
|
Video Recording | 1 | 2019 | 936 | 0.120 |
Why?
|
Biological Evolution | 1 | 2020 | 1072 | 0.120 |
Why?
|
Jaundice | 1 | 2014 | 89 | 0.120 |
Why?
|
Drug Monitoring | 1 | 2020 | 961 | 0.120 |
Why?
|
Hyperemia | 1 | 2015 | 224 | 0.120 |
Why?
|
Incidence | 5 | 2022 | 20913 | 0.120 |
Why?
|
Diabetic Nephropathies | 1 | 2021 | 981 | 0.120 |
Why?
|
Enalapril | 1 | 2015 | 323 | 0.120 |
Why?
|
Neisseria meningitidis | 1 | 2014 | 112 | 0.120 |
Why?
|
Iron, Dietary | 1 | 2014 | 141 | 0.120 |
Why?
|
Triage | 1 | 2020 | 975 | 0.120 |
Why?
|
Diabetes Mellitus, Type 2 | 4 | 2021 | 11699 | 0.110 |
Why?
|
Waist Circumference | 1 | 2017 | 912 | 0.110 |
Why?
|
Food Contamination | 1 | 2014 | 187 | 0.110 |
Why?
|
Liability, Legal | 1 | 2014 | 212 | 0.110 |
Why?
|
Acyclovir | 1 | 2013 | 272 | 0.110 |
Why?
|
Drug Hypersensitivity | 1 | 2022 | 889 | 0.110 |
Why?
|
Iron | 1 | 2021 | 1776 | 0.110 |
Why?
|
Developmental Disabilities | 1 | 2021 | 1445 | 0.110 |
Why?
|
Bacterial Capsules | 1 | 2014 | 254 | 0.110 |
Why?
|
Phenobarbital | 1 | 2013 | 190 | 0.110 |
Why?
|
Diuretics | 1 | 2015 | 590 | 0.110 |
Why?
|
Bacteria | 2 | 2020 | 2106 | 0.110 |
Why?
|
Drug Therapy, Combination | 2 | 2020 | 6478 | 0.110 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2020 | 941 | 0.110 |
Why?
|
Adult | 12 | 2022 | 213394 | 0.110 |
Why?
|
Adenosine Triphosphate | 1 | 2018 | 2022 | 0.100 |
Why?
|
Spain | 1 | 2013 | 463 | 0.100 |
Why?
|
Insulin-Secreting Cells | 1 | 2019 | 889 | 0.100 |
Why?
|
Virus Activation | 1 | 2013 | 319 | 0.100 |
Why?
|
National Practitioner Data Bank | 1 | 2011 | 13 | 0.100 |
Why?
|
Medical Records, Problem-Oriented | 1 | 2011 | 35 | 0.100 |
Why?
|
Hemoglobins | 1 | 2017 | 1529 | 0.100 |
Why?
|
Renal Dialysis | 1 | 2021 | 1780 | 0.100 |
Why?
|
Furans | 1 | 2012 | 186 | 0.100 |
Why?
|
Pilot Projects | 2 | 2015 | 8275 | 0.100 |
Why?
|
Nitric Oxide | 1 | 2020 | 2121 | 0.100 |
Why?
|
Risk Reduction Behavior | 2 | 2015 | 1123 | 0.100 |
Why?
|
Europe | 1 | 2017 | 3331 | 0.100 |
Why?
|
Food Hypersensitivity | 1 | 2018 | 613 | 0.100 |
Why?
|
Equipment Failure | 1 | 2013 | 580 | 0.090 |
Why?
|
Sodium, Dietary | 1 | 2014 | 416 | 0.090 |
Why?
|
Continuity of Patient Care | 1 | 2018 | 1054 | 0.090 |
Why?
|
Supine Position | 1 | 2011 | 210 | 0.090 |
Why?
|
General Practitioners | 1 | 2012 | 101 | 0.090 |
Why?
|
Cross-Sectional Studies | 4 | 2022 | 24714 | 0.090 |
Why?
|
Infusion Pumps, Implantable | 1 | 2011 | 156 | 0.090 |
Why?
|
Follow-Up Studies | 3 | 2019 | 38942 | 0.090 |
Why?
|
Primary Prevention | 1 | 2017 | 1165 | 0.090 |
Why?
|
Immunologic Factors | 1 | 2019 | 1571 | 0.090 |
Why?
|
Vaccines, Virosome | 1 | 2009 | 5 | 0.090 |
Why?
|
Diabetic Ketoacidosis | 1 | 2013 | 246 | 0.090 |
Why?
|
Splenectomy | 1 | 2011 | 392 | 0.090 |
Why?
|
Communicable Diseases | 1 | 2018 | 873 | 0.090 |
Why?
|
Chemistry, Pharmaceutical | 1 | 2011 | 285 | 0.090 |
Why?
|
Diffusion | 1 | 2011 | 832 | 0.090 |
Why?
|
Mutation | 4 | 2021 | 29658 | 0.090 |
Why?
|
Neurologic Examination | 1 | 2013 | 932 | 0.090 |
Why?
|
Physicians, Family | 1 | 2012 | 346 | 0.090 |
Why?
|
Off-Label Use | 1 | 2011 | 168 | 0.090 |
Why?
|
Outpatients | 2 | 2022 | 1469 | 0.090 |
Why?
|
Homozygote | 1 | 2014 | 1788 | 0.090 |
Why?
|
Blood-Borne Pathogens | 1 | 2009 | 52 | 0.090 |
Why?
|
Insulin, Long-Acting | 1 | 2009 | 57 | 0.090 |
Why?
|
Phenotype | 3 | 2021 | 16301 | 0.090 |
Why?
|
Streptococcus pneumoniae | 1 | 2015 | 714 | 0.090 |
Why?
|
Fluorescein Angiography | 1 | 2013 | 939 | 0.090 |
Why?
|
Dietary Carbohydrates | 1 | 2014 | 904 | 0.090 |
Why?
|
Baths | 1 | 2009 | 54 | 0.090 |
Why?
|
Dietary Proteins | 1 | 2014 | 959 | 0.080 |
Why?
|
Influenza A Virus, H3N2 Subtype | 1 | 2009 | 89 | 0.080 |
Why?
|
Prednisone | 1 | 2013 | 1560 | 0.080 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2015 | 1510 | 0.080 |
Why?
|
Immunity, Cellular | 1 | 2015 | 1603 | 0.080 |
Why?
|
Vancomycin Resistance | 1 | 2009 | 130 | 0.080 |
Why?
|
Adaptive Immunity | 1 | 2013 | 709 | 0.080 |
Why?
|
Hashimoto Disease | 1 | 2009 | 90 | 0.080 |
Why?
|
Gastroesophageal Reflux | 1 | 2015 | 782 | 0.080 |
Why?
|
Glucagon-Like Peptide 1 | 2 | 2021 | 331 | 0.080 |
Why?
|
Reminder Systems | 1 | 2011 | 370 | 0.080 |
Why?
|
Breast Feeding | 1 | 2016 | 1334 | 0.080 |
Why?
|
Enterococcus | 1 | 2009 | 161 | 0.080 |
Why?
|
Glucose | 1 | 2020 | 4377 | 0.080 |
Why?
|
Cytokines | 2 | 2020 | 7298 | 0.080 |
Why?
|
Chlorhexidine | 1 | 2009 | 161 | 0.080 |
Why?
|
Canada | 1 | 2013 | 2021 | 0.080 |
Why?
|
Health | 1 | 2011 | 390 | 0.080 |
Why?
|
Body Height | 1 | 2014 | 1577 | 0.080 |
Why?
|
Body Mass Index | 2 | 2017 | 12655 | 0.080 |
Why?
|
Artificial Intelligence | 1 | 2020 | 2124 | 0.080 |
Why?
|
Risk Management | 1 | 2011 | 571 | 0.080 |
Why?
|
Pregnancy | 2 | 2021 | 29002 | 0.070 |
Why?
|
Methicillin Resistance | 1 | 2008 | 198 | 0.070 |
Why?
|
Endothelium, Vascular | 2 | 2020 | 4454 | 0.070 |
Why?
|
Secondary Prevention | 1 | 2013 | 1516 | 0.070 |
Why?
|
Hematopoietic Stem Cell Transplantation | 2 | 2021 | 5401 | 0.070 |
Why?
|
Animals | 10 | 2021 | 168368 | 0.070 |
Why?
|
Anti-Infective Agents, Local | 1 | 2009 | 248 | 0.070 |
Why?
|
T-Lymphocyte Subsets | 1 | 2015 | 1834 | 0.070 |
Why?
|
Gram-Positive Bacterial Infections | 1 | 2009 | 341 | 0.070 |
Why?
|
Dietary Fats | 1 | 2014 | 2013 | 0.070 |
Why?
|
CD4 Lymphocyte Count | 1 | 2012 | 2602 | 0.070 |
Why?
|
Cooperative Behavior | 1 | 2013 | 1503 | 0.070 |
Why?
|
Drug Resistance, Viral | 1 | 2011 | 829 | 0.070 |
Why?
|
Documentation | 3 | 2022 | 861 | 0.070 |
Why?
|
Salvage Therapy | 1 | 2012 | 1269 | 0.070 |
Why?
|
Primary Health Care | 2 | 2021 | 4537 | 0.070 |
Why?
|
Immune System | 1 | 2011 | 801 | 0.070 |
Why?
|
Influenza A Virus, H1N1 Subtype | 1 | 2009 | 459 | 0.060 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2018 | 4424 | 0.060 |
Why?
|
Visual Acuity | 1 | 2013 | 2517 | 0.060 |
Why?
|
Proteomics | 1 | 2018 | 3584 | 0.060 |
Why?
|
Suicide | 1 | 2015 | 1469 | 0.060 |
Why?
|
Drug Industry | 1 | 2011 | 742 | 0.060 |
Why?
|
Epilepsy | 1 | 2020 | 3289 | 0.060 |
Why?
|
Forecasting | 1 | 2013 | 2952 | 0.060 |
Why?
|
Health Care Surveys | 1 | 2012 | 2448 | 0.060 |
Why?
|
Glucocorticoids | 1 | 2013 | 2100 | 0.060 |
Why?
|
Oxidative Stress | 1 | 2015 | 3087 | 0.060 |
Why?
|
Obesity | 3 | 2021 | 12643 | 0.060 |
Why?
|
Body Weight | 1 | 2014 | 4660 | 0.060 |
Why?
|
Viral Load | 1 | 2012 | 3299 | 0.060 |
Why?
|
Anticonvulsants | 1 | 2013 | 1907 | 0.060 |
Why?
|
Acute Kidney Injury | 1 | 2015 | 1941 | 0.060 |
Why?
|
Papillomavirus Infections | 1 | 2015 | 1585 | 0.060 |
Why?
|
Combined Modality Therapy | 1 | 2015 | 8605 | 0.060 |
Why?
|
Severity of Illness Index | 1 | 2020 | 15511 | 0.050 |
Why?
|
Pharmaceutical Preparations | 1 | 2011 | 1066 | 0.050 |
Why?
|
Cost-Benefit Analysis | 1 | 2015 | 5462 | 0.050 |
Why?
|
Virus Shedding | 1 | 2003 | 108 | 0.050 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 1 | 2009 | 694 | 0.050 |
Why?
|
Staphylococcal Infections | 2 | 2009 | 1403 | 0.050 |
Why?
|
Prospective Studies | 4 | 2022 | 53037 | 0.050 |
Why?
|
Data Collection | 1 | 2012 | 3341 | 0.050 |
Why?
|
Drug Resistance, Multiple | 1 | 2003 | 253 | 0.050 |
Why?
|
Energy Metabolism | 1 | 2013 | 2896 | 0.050 |
Why?
|
Longitudinal Studies | 2 | 2015 | 13880 | 0.050 |
Why?
|
Mass Screening | 1 | 2017 | 5265 | 0.050 |
Why?
|
Recurrence | 1 | 2013 | 8307 | 0.050 |
Why?
|
Inpatients | 2 | 2011 | 2478 | 0.050 |
Why?
|
Immunity, Innate | 1 | 2013 | 2950 | 0.050 |
Why?
|
Fructosamine | 1 | 2021 | 14 | 0.050 |
Why?
|
Gastric Inhibitory Polypeptide | 1 | 2021 | 59 | 0.050 |
Why?
|
Boston | 1 | 2014 | 9314 | 0.050 |
Why?
|
Immunotherapy | 1 | 2017 | 4391 | 0.050 |
Why?
|
Antiviral Agents | 1 | 2013 | 2971 | 0.050 |
Why?
|
Evidence-Based Medicine | 1 | 2013 | 3606 | 0.050 |
Why?
|
Ultrasonography | 1 | 2014 | 5941 | 0.050 |
Why?
|
Lipids | 1 | 2012 | 3307 | 0.050 |
Why?
|
Software | 1 | 2015 | 4423 | 0.050 |
Why?
|
Hotlines | 1 | 2020 | 55 | 0.050 |
Why?
|
Health Personnel | 1 | 2014 | 3203 | 0.050 |
Why?
|
Oropharynx | 1 | 2020 | 127 | 0.050 |
Why?
|
Parents | 1 | 2014 | 3368 | 0.050 |
Why?
|
Autoimmunity | 2 | 2018 | 1344 | 0.050 |
Why?
|
Reproducibility of Results | 1 | 2018 | 19811 | 0.040 |
Why?
|
Disease Models, Animal | 2 | 2021 | 18003 | 0.040 |
Why?
|
Glucose Transporter Type 1 | 1 | 2020 | 193 | 0.040 |
Why?
|
Staphylococcus aureus | 1 | 2008 | 1449 | 0.040 |
Why?
|
Genotype | 1 | 2014 | 12951 | 0.040 |
Why?
|
Case-Control Studies | 2 | 2020 | 21694 | 0.040 |
Why?
|
Diabetic Cardiomyopathies | 1 | 2020 | 96 | 0.040 |
Why?
|
Quality of Life | 2 | 2022 | 12640 | 0.040 |
Why?
|
RNA, Ribosomal, 23S | 1 | 2018 | 52 | 0.040 |
Why?
|
Organizational Case Studies | 1 | 2019 | 299 | 0.040 |
Why?
|
Feedback | 1 | 2022 | 788 | 0.040 |
Why?
|
New England | 1 | 2021 | 1021 | 0.040 |
Why?
|
Monosaccharide Transport Proteins | 1 | 2020 | 440 | 0.040 |
Why?
|
Bacterial Load | 1 | 2018 | 153 | 0.040 |
Why?
|
Fatal Outcome | 1 | 2003 | 1850 | 0.040 |
Why?
|
Antibodies, Viral | 1 | 2009 | 3151 | 0.040 |
Why?
|
Permeability | 1 | 2020 | 739 | 0.040 |
Why?
|
Serum Albumin | 1 | 2021 | 669 | 0.040 |
Why?
|
Sepsis | 1 | 2011 | 2571 | 0.040 |
Why?
|
Milk Proteins | 1 | 2018 | 168 | 0.040 |
Why?
|
United States | 2 | 2017 | 69573 | 0.040 |
Why?
|
Saliva | 1 | 2020 | 805 | 0.040 |
Why?
|
Signal Transduction | 1 | 2019 | 23355 | 0.030 |
Why?
|
Delivery of Health Care | 2 | 2011 | 5272 | 0.030 |
Why?
|
Cognition | 1 | 2013 | 6686 | 0.030 |
Why?
|
Intensive Care Units | 1 | 2009 | 3672 | 0.030 |
Why?
|
Sleep | 1 | 2011 | 4596 | 0.030 |
Why?
|
Surgical Wound Infection | 1 | 2004 | 1530 | 0.030 |
Why?
|
Clinical Trials as Topic | 1 | 2011 | 7897 | 0.030 |
Why?
|
Diagnostic Imaging | 1 | 2009 | 3497 | 0.030 |
Why?
|
Hypertrophy, Left Ventricular | 1 | 2020 | 851 | 0.030 |
Why?
|
Cardiovascular Diseases | 1 | 2020 | 15070 | 0.030 |
Why?
|
Child Day Care Centers | 1 | 2015 | 124 | 0.030 |
Why?
|
Medical Order Entry Systems | 1 | 2019 | 544 | 0.030 |
Why?
|
Retrospective Studies | 3 | 2022 | 76631 | 0.030 |
Why?
|
Diagnosis, Differential | 1 | 2009 | 12948 | 0.030 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2003 | 1513 | 0.030 |
Why?
|
Enzyme Activation | 1 | 2020 | 3701 | 0.030 |
Why?
|
Population Surveillance | 1 | 2004 | 2629 | 0.030 |
Why?
|
Mice, Inbred NOD | 1 | 2018 | 1867 | 0.030 |
Why?
|
Time Factors | 2 | 2019 | 40050 | 0.030 |
Why?
|
DNA, Bacterial | 1 | 2018 | 1467 | 0.030 |
Why?
|
Age of Onset | 1 | 2020 | 3263 | 0.030 |
Why?
|
Human papillomavirus 16 | 1 | 2015 | 261 | 0.030 |
Why?
|
Heart Septal Defects, Ventricular | 1 | 2015 | 485 | 0.030 |
Why?
|
Lung | 1 | 2011 | 9782 | 0.030 |
Why?
|
Genetic Predisposition to Disease | 1 | 2014 | 17384 | 0.030 |
Why?
|
Metformin | 1 | 2019 | 827 | 0.030 |
Why?
|
Cattle | 1 | 2018 | 3913 | 0.030 |
Why?
|
Middle Aged | 5 | 2022 | 212863 | 0.030 |
Why?
|
Heart Failure | 1 | 2015 | 10793 | 0.030 |
Why?
|
Aged | 4 | 2022 | 162698 | 0.020 |
Why?
|
Pandemics | 2 | 2022 | 8274 | 0.020 |
Why?
|
Drug Interactions | 1 | 2015 | 1456 | 0.020 |
Why?
|
Evaluation Studies as Topic | 1 | 2013 | 1676 | 0.020 |
Why?
|
Allergens | 1 | 2018 | 1308 | 0.020 |
Why?
|
Immunization | 1 | 2015 | 1255 | 0.020 |
Why?
|
Up-Regulation | 1 | 2019 | 4205 | 0.020 |
Why?
|
Inflammation | 2 | 2020 | 10534 | 0.020 |
Why?
|
Risk Assessment | 1 | 2011 | 23294 | 0.020 |
Why?
|
Reference Standards | 1 | 2013 | 1018 | 0.020 |
Why?
|
Interleukin-6 | 1 | 2019 | 3194 | 0.020 |
Why?
|
Dyslipidemias | 1 | 2017 | 851 | 0.020 |
Why?
|
Mice, Inbred BALB C | 1 | 2018 | 6397 | 0.020 |
Why?
|
Hypertension | 2 | 2020 | 8431 | 0.020 |
Why?
|
Electrophoresis, Gel, Pulsed-Field | 1 | 2008 | 144 | 0.020 |
Why?
|
Kidney Failure, Chronic | 1 | 2021 | 2546 | 0.020 |
Why?
|
Mice | 3 | 2021 | 81002 | 0.020 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2019 | 4400 | 0.020 |
Why?
|
Sex Factors | 1 | 2021 | 10398 | 0.020 |
Why?
|
Flow Cytometry | 1 | 2018 | 5959 | 0.020 |
Why?
|
Massachusetts | 1 | 2020 | 8669 | 0.020 |
Why?
|
Alcohol Drinking | 1 | 2020 | 3945 | 0.020 |
Why?
|
Patient Care | 1 | 2013 | 638 | 0.020 |
Why?
|
Lymphocyte Activation | 1 | 2018 | 5522 | 0.020 |
Why?
|
Insulin Resistance | 1 | 2020 | 3858 | 0.020 |
Why?
|
Gene Expression | 1 | 2019 | 7788 | 0.020 |
Why?
|
Brain | 1 | 2013 | 26345 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 1 | 2013 | 35326 | 0.020 |
Why?
|
Comorbidity | 1 | 2020 | 10362 | 0.020 |
Why?
|
Life Style | 1 | 2017 | 3817 | 0.020 |
Why?
|
Cell Line | 1 | 2019 | 15987 | 0.020 |
Why?
|
Stem Cells | 1 | 2017 | 3566 | 0.020 |
Why?
|
Atherosclerosis | 1 | 2020 | 3401 | 0.020 |
Why?
|
Cells, Cultured | 1 | 2020 | 19220 | 0.010 |
Why?
|
Smoking | 1 | 2020 | 8960 | 0.010 |
Why?
|
Phylogeny | 1 | 2008 | 2789 | 0.010 |
Why?
|
Prognosis | 1 | 2020 | 28901 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2017 | 21863 | 0.010 |
Why?
|
Cesarean Section | 1 | 2004 | 1371 | 0.010 |
Why?
|
Cross Infection | 1 | 2004 | 1414 | 0.010 |
Why?
|
Coronary Artery Bypass | 1 | 2004 | 2272 | 0.010 |
Why?
|
Mammaplasty | 1 | 2004 | 1185 | 0.010 |
Why?
|
Patient Discharge | 1 | 2004 | 3286 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2008 | 57650 | 0.000 |
Why?
|